Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.

Greenbaum L, Goldwurm S, Zozulinsky P, Lifschytz T, Cohen OS, Yahalom G, Cilia R, Tesei S, Asselta R, Inzelberg R, Kohn Y, Hassin-Baer S, Lerer B.

J Mol Neurosci. 2013 Oct;51(2):380-8. doi: 10.1007/s12031-013-0020-x. Epub 2013 May 12.

PMID:
23666822
2.

Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease.

Greenbaum L, Lorberboym M, Melamed E, Rigbi A, Barhum Y, Kohn Y, Khlebtovsky A, Lerer B, Djaldetti R.

Front Neurosci. 2013 Apr 15;7:52. doi: 10.3389/fnins.2013.00052. eCollection 2013.

3.

Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition.

Pelov I, Teltsh O, Greenbaum L, Rigbi A, Kanyas-Sarner K, Lerer B, Lombroso P, Kohn Y.

Psychiatr Genet. 2012 Aug;22(4):168-76. doi: 10.1097/YPG.0b013e3283518586.

4.

Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample.

Alkelai A, Greenbaum L, Lupoli S, Kohn Y, Sarner-Kanyas K, Ben-Asher E, Lancet D, Macciardi F, Lerer B.

PLoS One. 2012;7(1):e29228. doi: 10.1371/journal.pone.0029228. Epub 2012 Jan 11.

5.

Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model.

Greenbaum L, Lifschytz T, Zozulinsky P, Broner EC, Slonimsky A, Kohn Y, Lerer B.

Eur Neuropsychopharmacol. 2012 May;22(5):379-86. doi: 10.1016/j.euroneuro.2011.09.006. Epub 2011 Oct 6.

PMID:
21982117
6.

Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients.

Greenbaum L, Smith RC, Lorberboym M, Alkelai A, Zozulinsky P, Lifschytz T, Kohn Y, Djaldetti R, Lerer B.

Psychopharmacology (Berl). 2012 Apr;220(3):519-28. doi: 10.1007/s00213-011-2499-6. Epub 2011 Sep 24. Erratum in: Psychopharmacology (Berl). 2012 Apr;220(3):643. Lifshytz, Tzuri [corrected to Lifschytz, Tzuri].

PMID:
21947317
7.

Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree.

Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y.

Int J Neuropsychopharmacol. 2012 Apr;15(3):309-19. doi: 10.1017/S1461145711001374. Epub 2011 Sep 7.

PMID:
21899794
8.

Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.

Greenbaum L, Alkelai A, Zozulinsky P, Kohn Y, Lerer B.

Pharmacogenomics J. 2012 Dec;12(6):513-20. doi: 10.1038/tpj.2011.32. Epub 2011 Aug 2.

PMID:
21808285
9.

Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample.

Alkelai A, Lupoli S, Greenbaum L, Giegling I, Kohn Y, Sarner-Kanyas K, Ben-Asher E, Lancet D, Rujescu D, Macciardi F, Lerer B.

FASEB J. 2011 Nov;25(11):4011-23. doi: 10.1096/fj.11-184937. Epub 2011 Jul 27.

PMID:
21795503
10.

DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population.

Alkelai A, Lupoli S, Greenbaum L, Kohn Y, Kanyas-Sarner K, Ben-Asher E, Lancet D, Macciardi F, Lerer B.

Int J Neuropsychopharmacol. 2012 May;15(4):459-69. doi: 10.1017/S1461145711000903. Epub 2011 Jun 20. Erratum in: Int J Neuropsychopharmacol. 2012 May;15(4):541.

PMID:
21682944
11.

Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - role of gene-gene interaction, personality, and environmental factors.

Greenbaum L, Kanyas KS, Rigbi A, Alkelai A, Kohn Y, Lerer B.

Hum Psychopharmacol. 2010 Nov;25(7-8):536-42. doi: 10.1002/hup.1149. Epub 2010 Oct 25.

PMID:
21312287
12.

Association of reelin (RELN) single nucleotide polymorphism rs7341475 with prepulse inhibition in the Jewish Israeli population.

Greenbaum L, Levin R, Lerer E, Alkelai A, Kohn Y, Heresco-Levy U, Ebstein RP, Lerer B.

Biol Psychiatry. 2011 Mar 1;69(5):e17-8; author reply e19. doi: 10.1016/j.biopsych.2010.09.059. Epub 2010 Dec 31. No abstract available.

PMID:
21195391
13.

Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.

Greenbaum L, Alkelai A, Rigbi A, Kohn Y, Lerer B.

Mov Disord. 2010 Dec 15;25(16):2809-17. doi: 10.1002/mds.23377.

PMID:
20939080
14.

Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder.

Slonimsky A, Levy I, Kohn Y, Rigbi A, Ben-Asher E, Lancet D, Agam G, Lerer B.

Schizophr Res. 2010 Jul;120(1-3):159-66. doi: 10.1016/j.schres.2010.03.041. Epub 2010 May 8.

PMID:
20452750
15.

Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence.

Torri F, Akelai A, Lupoli S, Sironi M, Amann-Zalcenstein D, Fumagalli M, Dal Fiume C, Ben-Asher E, Kanyas K, Cagliani R, Cozzi P, Trombetti G, Strik Lievers L, Salvi E, Orro A, Beckmann JS, Lancet D, Kohn Y, Milanesi L, Ebstein RB, Lerer B, Macciardi F.

FASEB J. 2010 Aug;24(8):3066-82. doi: 10.1096/fj.09-152611. Epub 2010 Apr 6.

16.

No association between regulator of G-protein signaling 9 (RGS9) and schizophrenia in a Jewish population.

Greenbaum L, Pelov I, Teltsh O, Lerer B, Kohn Y.

Psychiatr Genet. 2010 Feb;20(1):47-8. doi: 10.1097/YPG.0b013e3283351234. No abstract available.

PMID:
20016399
17.

Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE, Irmansyah, Holmans PA, Escamilla M, Wildenauer DB, Williams NM, Laurent C, Mowry BJ, Brzustowicz LM, Maziade M, Sklar P, Garver DL, Abecasis GR, Lerer B, Fallin MD, Gurling HM, Gejman PV, Lindholm E, Moises HW, Byerley W, Wijsman EM, Forabosco P, Tsuang MT, Hwu HG, Okazaki Y, Kendler KS, Wormley B, Fanous A, Walsh D, O'Neill FA, Peltonen L, Nestadt G, Lasseter VK, Liang KY, Papadimitriou GM, Dikeos DG, Schwab SG, Owen MJ, O'Donovan MC, Norton N, Hare E, Raventos H, Nicolini H, Albus M, Maier W, Nimgaonkar VL, Terenius L, Mallet J, Jay M, Godard S, Nertney D, Alexander M, Crowe RR, Silverman JM, Bassett AS, Roy MA, Mérette C, Pato CN, Pato MT, Roos JL, Kohn Y, Amann-Zalcenstein D, Kalsi G, McQuillin A, Curtis D, Brynjolfson J, Sigmundsson T, Petursson H, Sanders AR, Duan J, Jazin E, Myles-Worsley M, Karayiorgou M, Lewis CM.

Mol Psychiatry. 2009 Aug;14(8):774-85. doi: 10.1038/mp.2008.135. Epub 2008 Dec 30.

18.

Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli families.

Alkelai A, Kohn Y, Olender T, Sarner-Kanyas K, Rigbi A, Hamdan A, Ben-Asher E, Lancet D, Lerer B.

Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):914-25. doi: 10.1002/ajmg.b.30918.

PMID:
19152384
19.

Cerebral perfusion after a 2-year remission in major depression.

Kohn Y, Freedman N, Lester H, Krausz Y, Chisin R, Lerer B, Bonne O.

Int J Neuropsychopharmacol. 2008 Sep;11(6):837-43. doi: 10.1017/S1461145708008936. Epub 2008 Jun 6.

PMID:
18534041
20.

Genome-wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, Arab Israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13.

Teltsh O, Kanyas K, Karni O, Levi A, Korner M, Ben-Asher E, Lancet D, Hamdan A, Lerer B, Kohn Y.

Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):209-15.

PMID:
17823922

Supplemental Content

Loading ...
Support Center